SpecificiT Pharma

SpecificiT Pharma a biopharmaceutical company that focuses on developing cellular therapies for hematological cancers that are untreatable with chimeric antigen receptor-modified T cells (CAR-T) therapies. Its approach directs unmodified donor T cells at minor histocompatibility antigens (MiHAs) to safely eliminate cancer cells in patients. In addition, the company employs a proprietary platform to discover tumor neoantigens to be used against solid tumors.